Caphosol Favorably Impacts Both The Rate And Severity Of Oral Mucositis In Cancer Patients
New data show that use of CAPHOSOL® (http://www.caphosol.com/), an advanced oral electrolyte solution, resulted in both favorable impact on rates and severity of oral mucositis (OM) in cancer patients undergoing chemotherapy and radiation therapy.
More: continued here
Filed under: Cancer on June 30th, 2008